recombinant MAGE-3.1 antigen
Term · Oncology and biomedicine · MLC-T-ONC-016446
A recombinant tumor-specific melanoma antigen. Vaccination with recombinant MAGE-3.1 antigen may induce a host immune response against MAGE-expressing cells, resulting in antitumoral T cell-mediated cytotoxicity. MAGE-expressing cells are found in melanoma, non-small-cell lung carcinoma (NSCLC), head and neck squamous cell carcinoma, transitional cell carcinoma of the bladder, and esophageal carcinoma.
| Identifier | MLC-T-ONC-016446 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | MAGE-3.1; MAGEA3; MAGE-3 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016446",
"term": "recombinant MAGE-3.1 antigen",
"field": "Oncology and biomedicine",
"definition": "A recombinant tumor-specific melanoma antigen. Vaccination with recombinant MAGE-3.1 antigen may induce a host immune response against MAGE-expressing cells, resulting in antitumoral T cell-mediated cytotoxicity. MAGE-expressing cells are found in melanoma, non-small-cell lung carcinoma (NSCLC), head and neck squamous cell carcinoma, transitional cell carcinoma of the bladder, and esophageal carcinoma.",
"synonyms": [
"MAGE-3.1",
"MAGEA3",
"MAGE-3"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/recombinant-mage-3-1-antigen/"
}
Record 14,196 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.